{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:12:07Z","timestamp":1791216727816,"version":"4.1.0"},"reference-count":5,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T00:00:00Z","timestamp":1580428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3,4]]},"abstract":"<jats:p>After treatment with vedolizumab, a patient with diarrhea and malnutrition secondary to common variable immune deficiency (CVID)\u2013related enteropathy was able to achieve clinical, endoscopic, and histological improvement. Vedolizumab may be a treatment option for patients with CVID-associated enteropathy.<\/jats:p>","DOI":"10.1093\/ibd\/izaa012","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T03:56:59Z","timestamp":1580443019000},"page":"e22-e23","source":"Crossref","is-referenced-by-count":11,"title":["Vedolizumab Induced Clinical, Endoscopic, and Histological Improvement in Common Variable Immunodeficiency Disease\u2013associated Intestinal Enteropathy"],"prefix":"10.1093","volume":"26","author":[{"given":"Hisham Javed","family":"Akhtar","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology, Western University, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharat","family":"Markandey","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4698-9948","authenticated-orcid":false,"given":"Christopher","family":"Ma","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darryl","family":"Ramsewak","sequence":"first","affiliation":[{"name":"Department of Radiology, Western University, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna C","family":"Walsh","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipul","family":"Jairath","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology, Western University, London, Ontario, Canada"},{"name":"Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,1,31]]},"reference":[{"key":"2020030403300145200_CIT0001","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(08)61199-X","article-title":"Common variable immunodeficiency: a new look at an old disease","volume":"372","author":"Park","year":"2008","journal-title":"Lancet."},{"key":"2020030403300145200_CIT0002","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/clim.1999.4725","article-title":"Common variable immunodeficiency: clinical and immunological features of 248 patients","volume":"92","author":"Cunningham-Rundles","year":"1999","journal-title":"Clin Immunol."},{"key":"2020030403300145200_CIT0003","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11894-016-0491-3","article-title":"Gastrointestinal disorders associated with Common Variable Immune Deficiency (CVID) and Chronic Granulomatous Disease (CGD)","volume":"18","author":"Uzzan","year":"2016","journal-title":"Curr Gastroenterol Rep."},{"key":"2020030403300145200_CIT0004","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1177\/0897190015579610","article-title":"Vedolizumab: a new opponent in the battle against crohn\u2019s disease and ulcerative colitis","volume":"29","author":"Poulakos","year":"2016","journal-title":"J Pharm Pract."},{"key":"2020030403300145200_CIT0005","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/ajg.2017.246","article-title":"Vedolizumab in patients with common variable immune deficiency and gut inflammation","volume":"112","author":"Boland","year":"2017","journal-title":"Am J Gastroenterol."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ibdjournal\/article-pdf\/26\/4\/e22\/32778595\/izaa012.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ibdjournal\/article-pdf\/26\/4\/e22\/32778595\/izaa012.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T03:30:48Z","timestamp":1583292648000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/26\/4\/e22\/5718328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,31]]},"references-count":5,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,1,31]]},"published-print":{"date-parts":[[2020,3,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izaa012","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,4]]},"published":{"date-parts":[[2020,1,31]]}}}